Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Eliminate expensive catalysts and harsh conditions in aryltrimethylstannane production. 95% yields, metal-free process, and scalable manufacturing for pharmaceutical intermediates.
Solve low yield and environmental issues in bis(3-amino-4-hydroxyphenyl)hexafluoropropane production. Our CDMO expertise delivers high-purity, scalable synthesis for aerospace and pharmaceutical applications.
Solve 4-arylbutyronitrile synthesis challenges with 100% atom economy, room-temperature visible light iron catalysis. Eliminate noble metals, reduce waste. Scale to 100MT/yr.
Discover how TEMPO/TBN catalysis enables room-temperature N-alkylation with 83% yield, eliminating oxidation agents and reducing supply chain risks for pharmaceutical intermediates.
Solve low yield & high cost in beta-nitroalcohol production. Our chiral copper catalysis achieves >95% yield, 96% ee, and green ethanol solvent. Scale to 100MT/yr.
Solve high-cost Pd-catalyzed synthesis challenges with green supercritical CO2 method. Achieve 55% yield, 99% purity, and simplified separation for bis-ferrocenyl pyridine derivatives. Reduce supply chain risks.
Solve chiral induction challenges with 97% yield axial diamine synthesis. Reduce R&D costs & scale production for pharma intermediates.
Eliminate toxic reagents and noble metals in tetracyclic quinazolinone production with 83% yield. Scale to 100MT/yr with NINGBO INNO PHARMCHEM's CDMO expertise.
Solve C-H activation challenges in pharmaceutical intermediates with green protonic acid catalysis. 91% yield, no precious metals, and industrial scalability for R&D and procurement teams.
Solve high-temperature synthesis challenges for 1,3-disubstituted allenes. Gold carbene catalysis enables room-temperature, high-yield (36-93%) production with excellent functional group tolerance. Scale up to 11g with NINGBO INNO PHARMCHEM.
Solve low-yield challenges in Balasubramide synthesis. 97% ee, 45% yield, no cytotoxicity. CDMO expertise for scalable production.
Discover metal-free visible light catalysis for 3-(2-pyridine) substituted pyrrole synthesis. Achieve 83-96% yields, eliminate heavy metal risks, and optimize your pharmaceutical supply chain.
Discover how this novel axial chiral phosphine catalyst enables high-yield, high-enantioselective synthesis for pharmaceutical intermediates, reducing production costs and supply chain risks.
Solve ASC-J9 supply chain challenges with 95% yield, 98.6% purity, and 3h reaction time. CDMO expertise for pharma scale.
Solve high-cost synthesis challenges with this air-ambient, metal-free method for trifluoroacetimide dihydrobenzofuran. Achieve >99% purity and scalable production for pharma intermediates.
Discover the breakthrough in spirooxindole synthesis with high yield and anti-tumor activity. Optimize your drug development process with this efficient method.
Solve metal residue issues in 3-thioindole production with metal-free photocatalysis. Achieve 70% yield, simplified process, and GMP compliance for your drug development projects.
Discover a cost-effective, high-yield synthesis for xianglanoside intermediates. Avoid silver catalysts, reduce byproducts, and ensure supply chain stability for cardiovascular drug development.
Overcome riociguat synthesis challenges: 40% yield, <0.05% impurity, and DMF-free process. NINGBO INNO PHARMCHEM delivers GMP-compliant production for your API needs.
Discover how chiral phosphoric acid catalysis enables high-yield, enantioselective synthesis of axial chiral aryl indoles for cancer drug development and supply chain de-risking.